Dr. Reddy's to Release Q3 FY13 Results on February 14, 2013

Earnings Call Slated for February 14, 6.30 PM IST / 8.00 AM EST*

HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy's Laboratories (NYSE: RDY) will announce results for the Third Quarter and Nine months ended December 31, 2012 on Thursday, February 14, 2013 after the Board Meeting. The results will be available on the Company’s website www.drreddys.com.

Summary of Events
Event	Date and Time (IST)	Medium
Release of financial results	February 14th, after the Board Meeting	Email, Media, Company website, Business Wire
Earnings Call	February 14th, 6.30 PM IST / 8.00 AM EST	Hosted by the Company (Details below)
Webcast of Earnings Call	February 14th, 6.30 PM IST / 8.00 AM EST through February 19th, 2013	URL available on Company’s website, www.drreddys.com
Transcripts of the Earnings call	Will be available on the Company’s website	URL available on Company’s website, www.drreddys.com

Earnings Call

Following the release, the management of the Company will host an earnings call to discuss the Company’s financial performance.

Conference Dial-In Numbers
Primary Number:	[phone]
Secondary Number:	[phone]
The numbers listed above are universally accessible from all networks and all countries.
	6000 1221
	Available in - Ahmedabad, Bangalore, Chennai, Cochin, Delhi (NCR), Hyderabad, Kolkata, Lucknow
Local Access Number:	Accessible from all major carriers except BSNL/MTNL.
	3940 3977
	Available in Ahmedabad, Bangalore, Chandigarh, Chennai, Cochin, Gurgaon (NCR), Hyderabad, Kolkata, Lucknow, Pune
	Accessible from all carriers.
	USA: 1 866 746 2133
International Toll Free Number:	UK: 0 808 101 1573
	Singapore: 800 101 2045
	Hong Kong: 800 964 448

No password/pin number is necessary to dial in to any of the other calls. As participation in the call is limited, early registration is encouraged. The operator will provide instructions on asking questions before and during the call.

Audio Webcast

The audio webcast of the earnings call will be available to all interested parties at www.drreddys.com. Please visit the web site at least fifteen minutes ahead of the scheduled start time to register and to download and install any necessary audio software. Participants in the webcast can listen to the proceedings, but will not be able to ask questions. The replay will be available 2 hours after the earnings call, through Feb 19th, 2013. For play back dial in phone No: 022 3065 1212 and ID: 375#.

Transcript

The transcript of the earnings call will also be available on the Company's website.

About Dr. Reddy’s

Dr. Reddy’s Laboratories Ltd. (NYSE: RDY) is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products – Dr. Reddy’s offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, biosimilars, differentiated formulations and NCEs. Therapeutic focus is on gastro-intestinal, cardiovascular, diabetology, oncology, pain management, anti-infective and pediatrics. Major markets include India, USA, Russia and CIS, Germany, UK, Venezuela, S. Africa, Romania, and New Zealand. For more information, log on to: www.drreddys.com.

*EST- Eastern Standard Time